Home
Centre for Cancer Biomarkers CCBIO
Course​

CCBIONEUR911 – Clinical Trials course 2026

The completed program qualifies for a Good Clinical Practice (GCP-R3) certificate and covers several aspects of clinical trials – from design planning to execution – with learning examples from cancer research and neurological research alike.

Speaker on stage, in front of a room fiull of course participants.
Photo:
CCBIO, Karen Rosnes Gissum

Main content

Clinical trials are studies performed in humans aimed at evaluating one or more medical, surgical, or behavioral intervention(s), and trials are the primary method to determine whether a new treatment is safe and effective. Most often, a clinical cancer or neurological disease trial compares the most effective known treatment for a specific type or stage of the disease with a new approach, although other designs are used more and more. Today, there are clinical trials for almost every type of cancer or neurological disease, and the numbers are increasing. While many trials focus on late-stage disease there are also trials for prevention and early diagnosis, and prevention of recurrence and survivorship.

Line Bjørge (CCBIO) and Christopher Elnan Kvistad (Neuro-SysMed) are academically responsible for the course, which is a collaboration between CCBIO and Neuro-SysMed. 

Course coordinators are Kjersti Tefre Davidsen (CCBIO, kjersti.tefre.davidsen@helse-bergen.no) and Gard Johanson (Neuro-SysMed, gard.johanson@uib.no).

When: January 14-16, 2026

Where: To be announced (campus Haukeland University Hospital)

Topics in the course:

  • What is a clinical study?
  • Study design
  • The pharmaceutical company perspective
  • The patient's perspective
  • Ethics
  • GCP overview and concepts
  • Introduction to GCP R3 with key updates from GCP R2
  • Practical running of a clinical trial
  • Formalities and regulations
  • Writing a protocol
  • Applications and funding
  • Contracts
  • Translational research protocols
  • Clinical trials as part of normal clinical operations
  • Success factors
  • Clinical trials in the future

Program: See the preliminary program here.

Registration: The deadline for ECTS providing registration is January 1, 2026. If you are already enrolled at the University of Bergen (UiB), you register through Studentweb

Available for non-ECTS participation: Yes, for those who need the Good Clinical Practice (GCP) certificate, and do not need the study points. Then, please use this link to apply to attend the course. A GCP certificate still requires participation throughout all parts of the course. The deadline is January 5, but the registration will be closed earlier if the course gets fully booked, which normally is the case with this course.

Open to all, and no fee.

ECTS: approved for 2 ECTS.

Read more at the student pages.